• Reset filters

Publications Apr 04, 2024

What’s going on with Australia’s proposed patent notification scheme for generic and biosimilar medicines?

The proposed patent notification scheme for generic and biosimilar medicines by the Australian Therapeutic Goods Administration (TGA) seems to have fallen of its priority list. Gavin Adkins, from our Law and Trade Marks team, reflects on the TGA’s consultation process, its subsequent announcements and the impact on innovators and generics.

Vaccines
Publications Feb 22, 2024

Australian Innovation Patents: Gone, but not forgotten

Amanda Stark and Dr Tim Fyfe discuss that innovation patents are still a useful tool for Australian patentees and can provide patent protection for subject matter that does not meet the threshold of patentability required for a standard patent.

Publications Dec 15, 2023

Comprising statements and the allure of inclusive construction

In this article, patent attorney Dr Megan Cole discusses how far a ‘comprising statement’ can push the inclusive boundaries.

Publications Jun 30, 2023

Australian Government again denied $325m damages claim in clopidogrel injunction dispute

The Full Court of the Federal Court of Australia has dismissed the Commonwealth’s appeal against a 2020 decision to deny it $325m in damages in a dispute relating to the antiplatelet drug clopidogrel.

News Jun 29, 2023

Griffith Hack announces four promotions, including two principal elevations

Griffith Hack is proud to announce the promotion of four team members, including the elevation of Dr James-Robert Cram and Kerry Dick to principal

cells
News Feb 10, 2023

Griffith Hack will be attending AUTM’s 2023 Annual Meeting in Austin, Texas

Griffith Hack is proud to sponsor the 2022 edition of the Fragment-Based Drug Discovery Down Under Conference.

biotech
Publications Nov 09, 2022

Are you patent ready? IP guidance for life sciences researchers

Whether you are an academic or industry-based researcher, the question is the same: when is the right time to file a patent application?

cells
News Sep 26, 2022

Griffith Hack sponsors Fragment-Based Drug Discovery Down Under Conference 2022

Griffith Hack is proud to sponsor the 2022 edition of the Fragment-Based Drug Discovery Down Under Conference.

Insights Aug 10, 2022

Karen Sinclair talks synthetic biology on the From Idea to Intellectual Property podcast

Karen Sinclair joins host Lisa Leong on the From Idea to Intellectual Property podcast series to discuss the emerging trends and key issues in the area of synthetic biology.

Publications Jun 01, 2022

Spotlight Series: Regenerative Medicine – Part 2

Welcome to the second article of our Spotlight Series on one of the most exciting frontiers of scientific research and innovation, regenerative medicine.

Publications Apr 06, 2022

Changes to how influencers can promote therapeutic goods in Australia

The Therapeutic Goods Administration has set out new guidelines that govern how influencers can promote products on social media in return for payment or free products or services from brands.

advanced manufacturing
Publications Mar 30, 2022

Federal Budget 2022: What’s in it to accelerate Australia’s innovation agenda?

We discuss the key measures in Australia’s 2022-23 federal budget that could help drive innovation, research commercialisation and business growth.

Publications Mar 07, 2022

From idea to inception and beyond: Important learnings from female biotech founders

Female biotech founders took centre-stage at AusBiotech 2021 with the leaders of some of Australia’s most innovative start-ups coming together to discuss their experiences in the commercial scientific world.

research team
Publications Mar 04, 2022

Saving grace: Options if you disclose your invention without a patent application 

Publicly disclosing new technology before a patent application has been filed can jeopardise patent coverage – but there are options available to you in the event of disclosure.

cells
Publications Mar 02, 2022

Virus filtration patent gets clean bill of health

In a recent decision of the Australian Patent Office, a patent application directed to a membrane for filtering biological products was upheld following opposition.

tablets
Publications Jan 28, 2022

Extending the 12-month grace period for filing patent applications – what you need to know

Can the 12-month grace period for filing your patent application be extended? Yes, it can – but subject to the facts.

biotech
Publications Oct 27, 2021

Why are embryonic stem cells not able to be patented in Australia?

Despite not being specifically excluded under s18 of the Australian Patents Act, technology utilising embryonic stem cells is not able to be patented in Australia. Why is this so?

chemistry
Publications Oct 20, 2021

Spotlight Series: Regenerative Medicine – Part 1

The first in a five-part series on one of the most exciting frontiers of scientific research and innovation, regenerative medicine.

research
Publications Aug 04, 2021

Draft roadmap for Australian regenerative medicine released for comment

AusBiotech has released a draft strategic roadmap for a new regenerative medicine Catalyst.

dna research
Publications Jul 02, 2021

Guidance on patenting diagnostics in Australia: Ariosa Diagnostics v Sequenom

Federal Court confirms that a non-invasive diagnostic test for prenatal conditions is patentable subject matter in Australia.

research
Publications Nov 18, 2020

Ono: Broader is not always better

Why is patent term extension is so important to companies developing and commercialising new pharmaceutical substances?

cells
Publications Jul 17, 2018

CRISPR-Cas9 Update: Collision of Trends in IP and Life Sciences

CRISPR-Cas9 genome editing may not just be the greatest scientific breakthrough of this century, but also provides many lessons on patenting life science technologies.